<html><body><pre>[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5122 Introduced in House (IH)]

&lt;DOC&gt;






114th CONGRESS
  2d Session
                                H. R. 5122

 To prohibit further action on the proposed rule regarding testing of 
               Medicare part B prescription drug models.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 29, 2016

  Mr. Bucshon (for himself, Mr. Dold, Mr. Boustany, Mr. Tom Price of 
  Georgia, and Mr. Shimkus) introduced the following bill; which was 
 referred to the Committee on Energy and Commerce, and in addition to 
   the Committee on Ways and Means, for a period to be subsequently 
   determined by the Speaker, in each case for consideration of such 
 provisions as fall within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
 To prohibit further action on the proposed rule regarding testing of 
               Medicare part B prescription drug models.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PROHIBITION OF FURTHER ACTION ON PROPOSED RULE REGARDING 
              TESTING OF MEDICARE PART B PRESCRIPTION DRUG MODELS.

    The Secretary of Health and Human Services may not take any action 
to finalize, implement, or enforce the proposed rule entitled 
``Medicare Program; Part B Drug Payment Model'' (81 Fed. Reg. 13230 
(March 11, 2016)).
                                 &lt;all&gt;
</pre></body></html>
